Intermittent bile acid therapy for cholesterol gallstones: a 5-year prospective multicentre trial.
1992-01-01 M. L. Petroni for the British Italian gallstone study G. r. o. u. p. R. P. Jazrawi, T. C. Northfield; Bristol: K. W. H., Heaton; Milan: E., Boga; M., Zuin; M., Podda; Lanzini, Alberto; Ferrara: D., Sighinolfi; P., Pazzi; V., Alvisi; Turin: M., Fracchia; G., Galatola; R., Ferraris
Factors predicting early response to treatment with recombinant interferon alpha-2° in chronic hepatitis C.
1992-01-01 Battezzzati, Pm; Podda, M; Bruno, S; Lanzini, Alberto
Gallstone pattern on computerised tomography (CT) is of value in predicting response to bile acid therapy.
1992-01-01 M. L., Petroni; R. P., Jazrawi; A., Grundy; Lanzini, Alberto; M. G., Pigozzi; A., Biasio; K., Heaton; J., Virjee; T. C., Northfield
Intermittent bile acid therapy for cholesterol gallstones: a 5-year prospective multicentre trial.
1992-01-01 M. L., Petroni; Al, ; Lanzini, Alberto; al for the British Italian Gallstone Study, Group
Long-term management and risk factors for recurrent cholesterol gallstones: a 5-year prospective multicentre trial.
1993-01-01 Petroni, 1. 0. 9. M. L.; R. P., Jazrawi; M., Zuin; E., Boga; Lanzini, Alberto; D., Facchinetti; M., Fracchia; G., Galatola; D., Sighinolfi; P., Pazzi; K. W. H., Heaton; R., Ferraris; V., Alvisi; M., Podda; T. C., Northfield
Interferon (IFN) vs interferon + tauro-ursodeoxycholic acid (t-UDCA) for treatment of chronic active hepatitis C (CHH-C): a multicentre randomised trial.
1995-01-01 M. G., Pigozzi; R., Sorbara; A., Reggiani; G. P., Lorini; C., Valsecchi; G., Viviani; M., De Tavonatti; A., Rotondi; L., Bettini; P., Tebaldi; Lanzini, Alberto
Prevalence of autoantibodies in patients with chronic hepatitis C (CHC): comparison with blood donors.
1995-01-01 Sorbara, R.; Pigozzi, M. G.; Tebaldi, P.; Franceschini, F.; Lanzini, Alberto
Long-term treatment with different regimens of recombinant interferon alpha in chronic hepatitis C.
1995-01-01 M., Podda; P. M., Battezzati; M., Zuin; S., Bruno; P., Gallotti; M., Borzio; E., Borzio; F., Fornari; Lanzini, Alberto; A., Salmi; A., Russo
Seroprevalence fo hepatitis A infection: relationship with socio-economic conditions.
1995-01-01 D., Facchinetti; A., Saleri; R., Negrini; Donato, Francesco; Lanzini, Alberto
Retention of a bile acid analogue in the enterohepatic circulation (EHC) in primary biliary cirrhosis (PBC): comparison with normal controls and effect of bile acid treatment.
1995-01-01 Detavonatti, M.; Panarotto, M. B.; Maira, G.; Franceschini, F.; Lanzarotto, F.; Lanzini, Alberto
Randomised comparative study of lymphoblastolid interferon (IFN) vs interferon + tauro-ursodeoxycholic acid (t-UDCA) in patients with chronic hepatitis C (CAH-C): efficacy of treatment at 6 months.
1995-01-01 M. G., Pigozzi; R., Sorbara; P., Tebaldi; A., Reggiani; D., Quattrocchi; G. P., Lorini; C., Lazzari; C., Valsecchi; G., Viviani; M., Detavonatti; A., Rotondi; L., Bettini; Lanzini, Alberto
Prevalence and risk factors for Helicobacter pylori (HP) infection in a recently developed area in northern Italy.
1995-01-01 D., Facchinetti; A., Saleri; Donato, Francesco; R., Negrini; Lanzini, Alberto
Long-term treatment with different regimens of recombinant interferon alpha in chronic hepatitis C.
1996-01-01 M., Podda; P. M., Battezzati; M., Zuin; S., Bruno; P., Gallotti; M., Borzio; F., Fornari; Lanzini, Alberto; A., Salmi; A., Russo
Is intestinal bile acid absorption up-regulated in primary biliary cirrhosis (PBC)? Comparison with health and effect of tauro-ursodeoxycholic acid (t-UDCA) treatment.
1996-01-01 Detavonatti, M.; Panarotto, M. B.; Franceschini, F.; Lanzarotto, F.; Lanzini, Alberto
75-SeHCAT retention test in chronic cholestatic disease: comparison with health and effect of bile acid therapy.
1995-01-01 Detavonatti, M.; Panarotto, M. B.; Franceschini, F.; Lanzarotto, F.; Lanzini, Alberto
Has tauro-ursodeoxycholic acid (T-UDCA) an interferon (IFN) sparing effect during treatment of chronic hepatitis?
1996-01-01 M. G., Pigozzi; R., Sorbara; A., Reggiani; C., Valsecchi; G. P., Lorini; G., Viviani; M., Detavonatti; L., Bettini; Lanzini, Alberto
Helicobacter pylori (HP) infection : a variable mode of transmission?
1996-01-01 D., Facchinetti; A., Saleri; R., Negrini; Donato, Francesco; Lanzini, Alberto
Is increased *-glutamyltranspeptidase (*GT) activity due to cholestasis in chronic hepatitis C (CHC) ?
1996-01-01 R., Sorbara; M. G., Pigozzi; A., Reggiani; A., Tagger; H., Ahmed; T. C., Northfield; S., Sosta; Lanzini, Alberto
Interferon (IFN) sparing effect of adjuvant tauro-ursodeoxycholic acid (T-UDCA) therapy for treatment of chronic hepatitis C. Results of liver histology.
1997-01-01 M. G., Pigozzi; R., Sorbara; A., Reggiani; M., Detavonatti; L. Bettini G. P., Lorini; C., Lazzari; A., Cominotti; M., Favret; S., Sosta; Lanzini, Alberto
Adjuvant tauro-ursodeoxycholic acid (T-UDCA) therapy for interferon (IFN) treatment of chronic hepatitis C.
1996-01-01 M. G., Pigozzi; R., Sorbara; A., Reggiani; G. P., Lorini; G., Viviani; M., Detavonatti; C., Carbone; A., Rotondi; L., Bettini; Lanzini, Alberto
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Intermittent bile acid therapy for cholesterol gallstones: a 5-year prospective multicentre trial. | 1-gen-1992 | M. L. Petroni for the British Italian gallstone study G. r. o. u. p. R. P. Jazrawi, T. C. Northfield; Bristol: K. W. H., Heaton; Milan: E., Boga; M., Zuin; M., Podda; Lanzini, Alberto; Ferrara: D., Sighinolfi; P., Pazzi; V., Alvisi; Turin: M., Fracchia; G., Galatola; R., Ferraris | |
| Factors predicting early response to treatment with recombinant interferon alpha-2° in chronic hepatitis C. | 1-gen-1992 | Battezzzati, Pm; Podda, M; Bruno, S; Lanzini, Alberto | |
| Gallstone pattern on computerised tomography (CT) is of value in predicting response to bile acid therapy. | 1-gen-1992 | M. L., Petroni; R. P., Jazrawi; A., Grundy; Lanzini, Alberto; M. G., Pigozzi; A., Biasio; K., Heaton; J., Virjee; T. C., Northfield | |
| Intermittent bile acid therapy for cholesterol gallstones: a 5-year prospective multicentre trial. | 1-gen-1992 | M. L., Petroni; Al, ; Lanzini, Alberto; al for the British Italian Gallstone Study, Group | |
| Long-term management and risk factors for recurrent cholesterol gallstones: a 5-year prospective multicentre trial. | 1-gen-1993 | Petroni, 1. 0. 9. M. L.; R. P., Jazrawi; M., Zuin; E., Boga; Lanzini, Alberto; D., Facchinetti; M., Fracchia; G., Galatola; D., Sighinolfi; P., Pazzi; K. W. H., Heaton; R., Ferraris; V., Alvisi; M., Podda; T. C., Northfield | |
| Interferon (IFN) vs interferon + tauro-ursodeoxycholic acid (t-UDCA) for treatment of chronic active hepatitis C (CHH-C): a multicentre randomised trial. | 1-gen-1995 | M. G., Pigozzi; R., Sorbara; A., Reggiani; G. P., Lorini; C., Valsecchi; G., Viviani; M., De Tavonatti; A., Rotondi; L., Bettini; P., Tebaldi; Lanzini, Alberto | |
| Prevalence of autoantibodies in patients with chronic hepatitis C (CHC): comparison with blood donors. | 1-gen-1995 | Sorbara, R.; Pigozzi, M. G.; Tebaldi, P.; Franceschini, F.; Lanzini, Alberto | |
| Long-term treatment with different regimens of recombinant interferon alpha in chronic hepatitis C. | 1-gen-1995 | M., Podda; P. M., Battezzati; M., Zuin; S., Bruno; P., Gallotti; M., Borzio; E., Borzio; F., Fornari; Lanzini, Alberto; A., Salmi; A., Russo | |
| Seroprevalence fo hepatitis A infection: relationship with socio-economic conditions. | 1-gen-1995 | D., Facchinetti; A., Saleri; R., Negrini; Donato, Francesco; Lanzini, Alberto | |
| Retention of a bile acid analogue in the enterohepatic circulation (EHC) in primary biliary cirrhosis (PBC): comparison with normal controls and effect of bile acid treatment. | 1-gen-1995 | Detavonatti, M.; Panarotto, M. B.; Maira, G.; Franceschini, F.; Lanzarotto, F.; Lanzini, Alberto | |
| Randomised comparative study of lymphoblastolid interferon (IFN) vs interferon + tauro-ursodeoxycholic acid (t-UDCA) in patients with chronic hepatitis C (CAH-C): efficacy of treatment at 6 months. | 1-gen-1995 | M. G., Pigozzi; R., Sorbara; P., Tebaldi; A., Reggiani; D., Quattrocchi; G. P., Lorini; C., Lazzari; C., Valsecchi; G., Viviani; M., Detavonatti; A., Rotondi; L., Bettini; Lanzini, Alberto | |
| Prevalence and risk factors for Helicobacter pylori (HP) infection in a recently developed area in northern Italy. | 1-gen-1995 | D., Facchinetti; A., Saleri; Donato, Francesco; R., Negrini; Lanzini, Alberto | |
| Long-term treatment with different regimens of recombinant interferon alpha in chronic hepatitis C. | 1-gen-1996 | M., Podda; P. M., Battezzati; M., Zuin; S., Bruno; P., Gallotti; M., Borzio; F., Fornari; Lanzini, Alberto; A., Salmi; A., Russo | |
| Is intestinal bile acid absorption up-regulated in primary biliary cirrhosis (PBC)? Comparison with health and effect of tauro-ursodeoxycholic acid (t-UDCA) treatment. | 1-gen-1996 | Detavonatti, M.; Panarotto, M. B.; Franceschini, F.; Lanzarotto, F.; Lanzini, Alberto | |
| 75-SeHCAT retention test in chronic cholestatic disease: comparison with health and effect of bile acid therapy. | 1-gen-1995 | Detavonatti, M.; Panarotto, M. B.; Franceschini, F.; Lanzarotto, F.; Lanzini, Alberto | |
| Has tauro-ursodeoxycholic acid (T-UDCA) an interferon (IFN) sparing effect during treatment of chronic hepatitis? | 1-gen-1996 | M. G., Pigozzi; R., Sorbara; A., Reggiani; C., Valsecchi; G. P., Lorini; G., Viviani; M., Detavonatti; L., Bettini; Lanzini, Alberto | |
| Helicobacter pylori (HP) infection : a variable mode of transmission? | 1-gen-1996 | D., Facchinetti; A., Saleri; R., Negrini; Donato, Francesco; Lanzini, Alberto | |
| Is increased *-glutamyltranspeptidase (*GT) activity due to cholestasis in chronic hepatitis C (CHC) ? | 1-gen-1996 | R., Sorbara; M. G., Pigozzi; A., Reggiani; A., Tagger; H., Ahmed; T. C., Northfield; S., Sosta; Lanzini, Alberto | |
| Interferon (IFN) sparing effect of adjuvant tauro-ursodeoxycholic acid (T-UDCA) therapy for treatment of chronic hepatitis C. Results of liver histology. | 1-gen-1997 | M. G., Pigozzi; R., Sorbara; A., Reggiani; M., Detavonatti; L. Bettini G. P., Lorini; C., Lazzari; A., Cominotti; M., Favret; S., Sosta; Lanzini, Alberto | |
| Adjuvant tauro-ursodeoxycholic acid (T-UDCA) therapy for interferon (IFN) treatment of chronic hepatitis C. | 1-gen-1996 | M. G., Pigozzi; R., Sorbara; A., Reggiani; G. P., Lorini; G., Viviani; M., Detavonatti; C., Carbone; A., Rotondi; L., Bettini; Lanzini, Alberto |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista1867
Data di pubblicazione
- In corso di stampa4
- 2020 - 202493
- 2010 - 2019624
- 2000 - 2009854
- 1990 - 1999209
- 1980 - 198983
Editore
- Association for Research in Visio...1
- Springer/plenum Publishers1
Rivista
- GIORNALE ITALIANO DI CARDIOLOGIA84
- ITALIAN HEART JOURNAL79
- EUROPEAN HEART JOURNAL52
- EUROPACE45
- GUT43
- EUROPEAN JOURNAL OF HEART FAILURE42
- DIGESTIVE AND LIVER DISEASE41
- EUROPEAN JOURNAL OF PUBLIC HEALTH39
- BLOOD38
- GIORNALE DI GERONTOLOGIA38
Keyword
- Health care indicators11
- Delphi method9
- Internet7
- Prospective study7
- elderly5
- eye-hand coupling5
- hepatitis C5
- Liver diseases5
- outcome indicators5
- Public health5
Lingua
- eng1037
- ita348
- fre1
Accesso al fulltext
- no fulltext1697
- open68
- reserved68
- restricted33
- partially open1